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Tazarotene-induced gene 3 (TIG3) is a tumor suppres-
sor protein. In normal human epidermis, TIG3 is
present in the differentiated, suprabasal layers, and it
regulates terminal differentiation. TIG3 level is reduced
in hyperproliferative diseases, including psoriasis and
skin cancer, suggesting that loss of TIG3 is associated
with enhanced cell proliferation. Moreover, transient
expression of TIG3 leads to terminal differentiation in
normal keratinocytes and apoptosis in skin cancer
cells. In both cell types, TIG3 distributes to the cell
membrane and to the centrosome. At the cell
membrane, TIG3 interacts with and activates type I
transglutaminase to enhance keratinocyte terminal
differentiation. TIG3 at the centrosome acts to inhibit
centrosome separation during mitosis and to alter
microtubule function. These findings argue that TIG3
is involved in the control of keratinocyte differentia-
tion and that loss of TIG3 in transformed cells con-
tributes to the malignant phenotype.
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THE EPIDERMIS AND TERMINAL DIFFERENTIATION
The epidermis is a multilayered tissue designed to provide
protection from the environment. The major epidermal cell
type is the keratinocyte, which differentiates to form basal,
spinous, granular, and cornified layers (Eckert et al., 1997).
Formation of these layers involves a process called differ-
entiation. The innermost epidermal layer, the basal layer,
contains undifferentiated/proliferative cells that undergo
regulated cell division (Pincelli and Marconi, 2010). A
fraction of basal cells undergo differentiation to form the
spinous, granular, and cornified layers. The layer immediately
adjacent to the basal layer is the spinous layer that is
distinguished by a spinous appearance. The next layer,
the granular layer, consists of cells having intracellular
membrane-bound granules, which contain proteins and
lipids required for the formation of the epidermal barrier.
Basal layer cells have proliferative potential, but cells in the
spinous and granular layers, although viable, do not pro-
liferate. This change in differentiation status is associated with
stage-specific changes in protein expression. For example,
basal cells express keratins 5 and 14, whereas suprabasal cells
express differentiation markers including type I transgluta-
minase (TG1), involucrin, loricrin, filaggrin, keratin 1, and
keratin 10 (Eckert et al., 1997). Cells in the outermost
‘‘cornified layer’’ undergo terminal differentiation, which
involves loss of the nuclei and assembly of the cornified
envelope. These fully differentiated cells are called corneo-
cytes, which consist of a network of stabilized keratin
surrounded by a covalently cross-linked envelope of protein.
Many envelope precursor proteins have been identified,
including involucrin, cystatin-a, loricrin, elafin, small proline-
rich proteins, filaggrin, and keratin (Eckert et al., 1997). These
precursor proteins are covalently cross-linked to form the
cornified envelope by TG1, which is anchored to the inner
surface of the plasma membrane and catalyzes the formation
of e-(g-glutamyl)lysine protein–protein cross-links (Chakravarty
and Rice, 1989). The ultimate function of the epidermis is to
provide a protective barrier. This process is tightly controlled,
and a current area of interest is identifying proteins that control
this process. Tazarotene-induced gene 3 (TIG3) is an
important regulator of cell survival that has an important
role in this process (Eckert et al., 2009).
TIG3
TIG3, also known as retinoid-induced gene 1 and retinoic acid
receptor responder 3, is a tumor suppressor protein composed
of 164 amino acids (Huang et al., 2000; Jiang et al., 2005; Tsai
et al., 2007; Ou et al., 2008). TIG3 was discovered in
keratinocytes treated with the synthetic retinoid tazarotene
(DiSepio et al., 1998). TIG3 shares sequence similarity with
members of the H-rev107 family of tumor suppressors, and is
over 50% identical to human and rat H-rev107 (DiSepio et al.,
1998). H-rev107 family members also show homology with
the lecithin retinol acyltransferase family and NlpC/P60 super
family (Hajnal et al., 1994; Husmann et al., 1998;
Anantharaman and Aravind, 2003; Jahng et al., 2003). The
H-rev107 family of proteins shares a common structure that
includes N-terminal hydrophilic and C-terminal hydrophobic
domains. The TIG3 N-terminal domain comprises 134 amino
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acids and the C-terminal region comprises 30 amino acids
(Figure 1). The N terminus includes several conserved
elements, including the N-terminal homology domain, and
the NCEHFV and LRYG motifs. The C terminus contains fewer
conserved elements, and mutagenesis studies suggest that it
serves as a membrane-anchoring domain (Figure 1) (Deucher
et al., 2000).
TIG3 REGULATES KERATINOCYTE TERMINAL
DIFFERENTIATION
TIG3 is selectively expressed in differentiating cells and during
programmed cell death. As such, TIG3 is expressed at vanish-
ingly low levels in proliferating keratinocytes in monolayer
culture, but it is expressed at high levels in differentiated
human epidermis and keratinocytes grown as epidermal
equivalents (Duvic et al., 1997, 2000; Sturniolo et al., 2003;
Jans et al., 2008). This pattern of expression suggests that TIG3
is involved in differentiation and survival processes. Transient
expression of TIG3 in keratinocytes, at levels within the
physiological range observed in differentiated keratinocytes
(Jans et al., 2008), is associated with a marked morphological
change. TIG3-positive cells display a morphology that
resembles that of a terminal corneocyte (Sturniolo et al.,
2003). This morphological change is associated with
reduced cell survival (Deucher et al., 2000; Sturniolo et al.,
2003, 2005; Jans et al., 2008; Eckert et al., 2009). In fact, the
expression of TIG3 in cultures of normal keratinocytes results
in nearly quantitative cornification (Sturniolo et al., 2003,
2005), suggesting that TIG3 is an inducer of keratinocyte
differentiation. Consistent with a potential role in enhancing
keratinocyte differentiation, TIG3 levels are reduced in
epidermal hyperproliferative disease and cancer (Eckert
et al., 1997; DiSepio et al., 1998; Deucher et al., 2000;
Duvic et al., 2000, 2003; Jans et al., 2008).
Several studies have examined the role of TIG3 in control-
ling intracellular processes and how this correlates with
intracellular localization. These studies show that TIG3
localizes at the keratinocyte plasma membrane via a mechan-
ism that requires the TIG3 C-terminal hydrophilic membrane-
anchoring domain (Sturniolo et al., 2003, 2005; Eckert et al.,
2009). A key finding is that membrane-associated TIG3
interacts with TG1 at this location (Sturniolo et al., 2003,
2005; Eckert et al., 2009). TG1 is anchored to the inner
surface of the plasma membrane by a lipid anchor
(Chakravarty and Rice, 1989; Phillips et al., 1993) and is
responsible for catalyzing the formation of the protein–protein
cross-links required for cornified envelope assembly. It has
been proposed that newly synthesized TIG3 inserts in the
plasma membrane, translocates in the membrane to locate
TG1, and that a TIG3/TG1 interaction drives the activation of
TG1. Indeed, confocal studies reveal that TIG3 colocalizes
with TG1 in keratinocytes (Sturniolo et al., 2003, 2005; Jans
et al., 2008), and that TG1 activity is observed at these sites.
Moreover, biochemical pull-down experiments reveal that
TIG3 co-precipitates with TG1 (Sturniolo et al., 2003, 2005;
Jans et al., 2008). This requires the full-length TIG3 protein, as
removal of the C-terminal membrane-anchoring domain from
TIG3 results in a loss of interaction (Sturniolo et al., 2003,
2005). These studies suggest that the inability of the TIG3
C-terminal truncation mutant to interact with TG1 is because
the mutant does not localize at the plasma membrane
(Deucher et al., 2000; Sturniolo et al., 2003; Jans et al.,
2008). Additional studies identify a TIG3 region at the junction
between the N-terminal domain and the C-terminal
membrane-anchoring domain as being required for interac-
tion with TG1 (Jans et al., 2008) (Figure 1). The interaction of
TIG3 with TG1 leads to increased TG1 activity (Sturniolo
et al., 2003, 2005), and the increase in TG1 activity is
associated with reduced cell survival. The reduction in cell
survival can be partially inhibited by monodansylcadaverine,
a TG1 substrate competitive inhibitor (Sturniolo et al., 2005).
TIG3 is one of the only few proteins that interact with TG1 to
increase activity (Jans et al., 2008; Eckert et al., 2009). Similar
to most proteins that interact with TG1, TIG3 also functions as
a substrate (Sturniolo et al., 2005). As expected, the TIG3
mutant lacking the membrane-localization domain does not
interact with TG1 and is not a substrate (Sturniolo et al., 2003,
2005). These findings support the hypothesis that TIG3
regulates key events during terminal keratinocyte differentia-
tion and that interaction at the cell membrane is a requirement
for TIG3 function. We propose that TIG3 is produced, moves
to the membrane where it is anchored by the C-terminal
hydrophobic domain, and that it then moves in the membrane
until it contacts and activates TG1. This ultimately leads to
the cross-linking of cornified envelope precursors and
envelope assembly (Figure 2). We further propose that
removing the C-terminal region (green) results in an inability
of TIG3 to drive activation, owing to its inability to localize
with TG1.
TIG3 AT THE CENTROSOME
In addition to localizing at the plasma membrane, TIG3 is also
observed at a perinuclear location. Keratinocytes were stained
with anti-TIG3 and antibodies that detect organelle-
specific proteins including pericentrin (centrosome), g-tubulin
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Figure 1. Structure of tazarotene-induced gene 3 (TIG3) and interaction with
transglutaminase. TIG3 is a 164-amino-acid protein that is divided into
N-terminal (purple, amino acids 1–134) and C-terminal (green, amino acids
135–164) domains. The N-terminal hydrophilic domain includes regions
(orange vertical bars) that are highly conserved among members of the
H-rev107 family of tumor suppressor proteins (Deucher et al., 2000). The type I
transglutaminase (TG1) interaction domain and the centrosome interaction
domain are indicated, as are the N-terminal homology domain and the
NCEHFV and LRYG motifs.
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(centrosome), GM130 (cis-Golgi apparatus), mannose-6-phos-
phate receptor (M6PR, trans-Golgi and late endosome), rab11
(recycling endosome), EEA1 (early endosome), clathrin heavy
chain (intracellular transport vesicle), lamp1 (lysosome),
calnexin (endoplasmic reticulum), and Mitotracker Red
(mitochondria). TIG3 localizes with pericentrin and g-tubulin
in 90% of cells (Scharadin et al., 2011). In addition, some
colocalization is observed with the Golgi (GM130 and M6PR)
markers, which is consistent with the observation that TIG3
localizes at the Golgi in cervical cancer cells (Tsai et al., 2007;
Scharadin et al., 2012). TIG3 localization in the vicinity of the
centrosome suggests that TIG3 may affect centrosome-related
functions.
TIG3 impact on microtubule distribution and elongation
The centrosome (microtubule organizing center) is a 1–2-mm-
diameter organelle that functions as a site of microtubule
assembly (Doxsey et al., 2005; Tsai et al., 2007; Lim et al.,
2009). Microtubules form from a- and b-tubulin heterodimers
that nucleate at the centrosome (Doxsey et al., 2005). This
microtubule network has two main functions in the cell. In
interphase cells, the microtubules serve as a highway to guide
and regulate intracellular cargo movement. The cargo
includes proteins, vesicles, and organelles. Cargo is bound
to the microtubules by molecular motors, called kinesins and
dineins, which control anterograde (away from centrosome)
and retrograde (toward centrosome) movement. The second
role of the centrosome is to assemble the mitotic spindles that
guide chromosome movement during mitosis. Both of these
functions are absolutely essential for cell division and survival
(Doxsey et al., 2005).
The presence of TIG3 in the vicinity of the centrosome
suggests that TIG3 may alter centrosome function. Recent
reports support this hypothesis. Keratinocytes that transiently
overexpress TIG3 display marked changes in cell division
and status of the microtubule network. In control cells, the
microtubule network radiates from the centrosome throughout
the cell. In contrast, in TIG3-expressing cells, the microtubules
redistribute to the cell periphery where they form a thick band
adjacent to the cell membrane that is linked to the centrosome
by thin microtubule ‘‘spokes’’ (Scharadin et al., 2012). This
rearrangement is accompanied by microtubule stability-
inducing post-translational modification of a-tubulin (Scharadin
et al., 2011), including increased acetylation of lysine 40 and
detyrosination of the C-terminal tyrosine of a-tubulin (Hammond
et al., 2008; Ikegami and Setou, 2010; Quinones et al., 2011).
The latter modification results in the formation of D2-a-tubulin,
a highly stable form of a-tubulin. These modifications markedly
increase microtubule stability (Gundersen et al., 1987).
However, in spite of the presence of these stabilizing modi-
fications in TG3-positive cells, the peripheral microtubule band
remains susceptible to disruption by nocodazole (Scharadin
et al., 2012) and reforms upon nocodazole removal (Scharadin
et al., 2012). Thus, the impact of TIG3 on microtubule dynamics
requires further study. The changes in microtubule organization
are consistent with an impact of TIG3 on centrosome function.
This is supported by studies of microtubule elongation.
Microtubule anterograde growth can be measured in real time
in live cells using the plus-end binding protein EB1 (Piehl et al.,
2004; Jaworski et al., 2008; Dixit et al., 2009). Fluorescently
labeled EB1 studies in control cells reveal abundant anterograde
microtubule growth and show that this growth is markedly
attenuated in TIG3-expressing cells. In contrast, although the
initiation of microtubule formation is maintained in TIG3-
positive cells, subsequent elongation of these microtubules is
severely attenuated (Scharadin et al., 2012). This suggests that
TIG3 may suppress centrosome-dependent intracellular cargo
distribution.
TIG3 IMPACT ON CENTROSOME SEPARATION
TIG3 also affects the centrosome during mitosis. During
normal cell division, the centrosome is duplicated along with
the chromosomes during the S-phase of the cell cycle.
Subsequently, in early prophase, the daughter centrosomes
separate and initiate the formation of radial arrays of micro-
tubules, known as asters. The asters then move to opposite
poles of the cell during metaphase and serve to form the
mitotic spindle, which interacts with the chromosomes
throughout mitosis. A critical and necessary step is the separa-
tion of the daughter centrosomes and their migration to the
spindle poles. The impact of TIG3 on centrosome function
during mitosis was studied by monitoring centrosome separa-
tion (Doxsey et al., 2005). In control keratinocytes, 16% of
cells display separated daughter centrosomes, which corres-
ponds to the percentage of dividing cells. In comparison, only
one percent of TIG3-positive cells display centrosome
separation (Scharadin et al., 2012). This difference is not due
to TIG3-associated suppression of new centrosome formation,
as centrosome synthesis is unchanged in control and TIG3-
positive cells (Scharadin et al., 2012). This inhibition of
centrosome separation affects cell division. Keratinocytes
that express TIG3 display a significant reduction in the
uptake of the S-phase cell cycle marker bromodeoxyuridine.
Approximately 14% of TIG3-negative keratinocytes, versus
1% of TIG3-expressing keratinocytes, are in S-phase
TIG3
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Figure 2. Tazarotene-induced gene 3 (TIG3) interaction with type I
transglutaminase (TG1). TIG3 is produced in differentiated keratinocytes and is
anchored to the plasma membrane via the C-terminal membrane-anchoring
domain (green). TG1 is tethered to the plasma membrane via a lipid anchor
(Chakravarty and Rice, 1989). TIG3 interaction with TG1 produces a complex
that activates TG1 enzymatic activity, which leads to cornified envelope
assembly. It is very likely that the TIG3/TG1 complex also includes other
proteins.
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(Scharadin et al., 2012). These findings support the hypothesis
that TIG3 distribution to the centrosome inhibits centrosome
separation and secondarily inhibits cell division.
TIG3 INTRACELLULAR LOCALIZATION AND CONTROL
OF CELL FUNCTION
A key question is how the cell regulates TIG3 distribution
between the plasma membrane and the centrosome. The
mechanism is not well understood. Recent studies used a
series of TIG3 mutants fused to enhanced green fluorescent
protein. These studies identified amino acids 102–125 as
sufficient to mobilize enhanced green fluorescent protein to
the centrosome (Scharadin et al., 2013). The presence of a
centrosome localization sequence at amino acids 102–125 is
particularly interesting, as this region encodes amino acids
that are highly conserved when TIG3 is compared with other
members of the H-rev107 tumor suppressor family (Deucher
et al., 2000), suggesting that centrosome-associated action
may be a property of other family members. Moreover, TIG3
peptides, derived from within this region (amino acids 111-
123), are able to reduce cell survival in some cell types
(Simmons et al., 2006).
The microtubule rearrangement displayed in cultured TIG3-
expressing keratinocytes may have an important in vivo
correlate. In the basal cells of the mouse epidermis, the
microtubule network emanates from the centrosome. In
suprabasal differentiated cells, in contrast, the microtubules
preferentially distribute to cell–cell junctions and form a
microtubule band at the cell periphery (Lechler and Fuchs,
2007; Scharadin et al., 2011, 2012). It has been proposed
that this microtubule redistribution is driven by ninein,
a microtubule-anchoring protein. Ninein moves to the cell
periphery in differentiated cells (Mogensen et al., 2000;
Dammermann and Merdes, 2002; Delgehyr et al., 2005;
Lechler and Fuchs, 2007). Preliminary studies indicate that
TIG3 expression in human keratinocytes does not alter ninein
distribution in human keratinocytes (TM Scharadin and RL
Eckert, unpublished). Although further studies are necessary to
elucidate the mechanism whereby TIG3 alters microtubule
distribution, it is intriguing that TIG3 causes microtubules to
distribute to the cell periphery in a pattern similar to that
observed in suprabasal keratinocytes in the epidermis
(Scharadin et al., 2013). Thus, elevated TIG3 in the
suprabasal epidermis may contribute to the microtubule
redistribution observed in differentiated cells in vivo.
TIG3 IN HYPERPROLIFERATIVE DISEASE
As mentioned above, TIG3 is observed at reduced levels in
skin cancer and epidermal hyperproliferative disease (DiSepio
et al., 1998). This suggests that the absence of TIG3 may be a
permissive event in skin carcinogenesis. On the basis of this
information, restoration of TIG3 expression in hyperpro-
liferative diseases would be predicted to reduce cell
proliferation and survival. Endogenous TIG3 levels can be
increased by treating cells with tazarotene or other retinoids
(DiSepio et al., 1998; Huang et al., 2000; Higuchi et al., 2003;
Jiang et al., 2005). Retinoid-dependent increased TIG3
expression is also observed in retinoid-treated psoriatic
lesions (Duvic et al., 2000, 2003; ; Talpur et al., 2009). This
is consistent with observations in cultured keratinocytes.
Transient expression of TIG3 in normal keratinocytes leads
to a reduction in cell proliferation (Deucher et al., 2000;
Sturniolo et al., 2003, 2005; Jans et al., 2008; Eckert et al.,
2009). Further, transient expression of TIG3 suppresses growth
in cell lines created from several types of cancers, including
lung, head and neck, gastric, cervical, and prostate cancer
(DiSepio et al., 1998; Deucher et al., 2000; Huang et al.,
2000, 2002; Higuchi et al., 2003; Kawakami et al., 2006).
Consistent with a role in suppressing proliferation/increasing
cell death, enhanced TIG3 expression is observed in tau
neuropathies where it is associated with increased neuronal
cell death (Wilhelmus et al., 2011). TIG3 suppression of cell
survival was also studied using epidermis-derived squamous
cell carcinoma cells. These tumor cells proliferate rapidly, and
restoring TIG3 expression slows cell proliferation (Scharadin
et al., 2011). Expression of TIG3 in cancer cells activates
caspases 3 and 9 and PARP cleavage, leading to apoptosis
(Scharadin et al., 2011). In addition, TIG3 reduces the level of
G1 and G1/S-phase cell cycle regulatory proteins including
cyclin D, cyclin E, cdk4, and cdk6. This leads to a cell cycle
block at the G1/S-phase transition (Scharadin et al., 2011). The
G1/S block is associated with increased expression of p21Cip1
mRNA and protein (Scharadin et al., 2011). Elevated
TIG3 expression in other keratinocyte cell lines, including
the immortalized HaCaT keratinocyte cell line and the
transformed A431 squamous cell carcinoma cell line, yields
similar results (TM Scharadin and RL Eckert, unpublished). The
observation that TIG3 causes apoptosis in cancer cells is in
contrast to the findings in normal human keratinocytes where
it causes differentiation (Sturniolo et al., 2003, 2005; Jans
et al., 2008; Eckert et al., 2009; Scharadin et al., 2011). As
mentioned above, TIG3 enhances normal keratinocyte
terminal differentiation, in part through binding to, and activa-
tion of, TG1, but it does not activate apoptosis (Sturniolo et al.,
2003; Jans et al., 2008). Interestingly, TIG3 is distributed to the
cell membrane and the centrosome in normal keratinocytes
and skin cancer cell lines (Scharadin et al., 2011). Thus,
although TIG3 displays a similar pattern of localization in
cancer and normal cells, the net outcome (differentiation or
apoptosis) is different in the two cell types. Understanding the
mechanistic basis for this difference will require additional
study.
SUMMARY
TIG3 is a regulator of keratinocyte proliferation and terminal
differentiation that is expressed in the suprabasal differentiated
epidermis. We propose that onset of TIG3 expression in the
suprabasal epidermis is an integral event in the process that
reduces cell proliferation and enhances terminal differentia-
tion. In this role, recent studies suggest that TIG3 operates via
interaction at two major subcellular locations. The first
location is the plasma membrane where it interacts with
TG1 to increase activity leading to increased cornified envelope
assembly (Duvic et al., 2000; Sturniolo et al., 2003, 2005; Jans
et al., 2008) (Figure 3c). The second location is the centro-
some, where TIG3 acts to alter microtubule function and
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inhibit centrosome separation. TIG3 presence promotes a
redistribution of the microtubules to form a peripheral band
near the plasma membrane (Figure 3b). The a-tubulin subunit
in these microtubules is altered by covalent modifications that
reduce microtubule turnover and increase stability (Scharadin
et al., 2011, 2012). TIG3 also suppresses daughter centrosome
separation, which is associated with reduced cell proliferation
(Scharadin et al., 2011, 2012) (Figure 3a). Finally, consistent
with enhanced cell survival, TIG3 levels are reduced in
hyperproliferative skin disorders, including psoriasis and skin
cancer (Duvic et al., 1997, 2000, 2003; Talpur et al., 2009).
We propose that TIG3 has a dual role to drive growth
cessation and differentiation in maturing epidermis. It acts at
the centrosome to inhibit centrosome separation and promote
microtubule rearrangement to impede cell division, and it also
acts at the plasma membrane to activate transglutaminase to
stimulate cornified envelope formation.
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